Literature DB >> 22807023

Null but not void: considerations for hypothesis testing.

Pamela A Shaw1, Michael A Proschan.   

Abstract

Standard statistical theory teaches us that once the null and alternative hypotheses have been defined for a parameter, the choice of the statistical test is clear. Standard theory does not teach us how to choose the null or alternative hypothesis appropriate to the scientific question of interest. Neither does it tell us that in some cases, depending on which alternatives are realistic, we may want to define our null hypothesis differently. Problems in statistical practice are frequently not as pristinely summarized as the classic theory in our textbooks. In this article, we present examples in statistical hypothesis testing in which seemingly simple choices are in fact rich with nuance that, when given full consideration, make the choice of the right hypothesis test much less straightforward. Published 2012. This article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22807023      PMCID: PMC4034366          DOI: 10.1002/sim.5497

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  8 in total

1.  Comparisons of two-part models with competitors.

Authors:  P A Lachenbruch
Journal:  Stat Med       Date:  2001-04-30       Impact factor: 2.373

2.  Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials.

Authors:  Peter B Gilbert; Ronald J Bosch; Michael G Hudgens
Journal:  Biometrics       Date:  2003-09       Impact factor: 2.571

3.  Sensitivity analyses comparing outcomes only existing in a subset selected post-randomization, conditional on covariates, with application to HIV vaccine trials.

Authors:  Bryan E Shepherd; Peter B Gilbert; Yannis Jemiai; Andrea Rotnitzky
Journal:  Biometrics       Date:  2006-06       Impact factor: 2.571

4.  A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trial.

Authors:  Devan V Mehrotra; Xiaoming Li; Peter B Gilbert
Journal:  Biometrics       Date:  2006-09       Impact factor: 2.571

5.  Effects of delays in peripheral blood processing, including cryopreservation, on detection of CD31 expression on naive CD4 T cells.

Authors:  Jeanette Higgins; Julia A Metcalf; Randy A Stevens; Michael Baseler; Michael Proschan; H Clifford Lane; Irini Sereti
Journal:  Clin Vaccine Immunol       Date:  2008-04-30

6.  Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

Authors:  David D Waters; Edwin L Alderman; Judith Hsia; Barbara V Howard; Frederick R Cobb; William J Rogers; Pamela Ouyang; Paul Thompson; Jean Claude Tardif; Lyall Higginson; Vera Bittner; Michael Steffes; David J Gordon; Michael Proschan; Naji Younes; Joel I Verter
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

7.  A close look at therapeutic touch.

Authors:  L Rosa; E Rosa; L Sarner; S Barrett
Journal:  JAMA       Date:  1998-04-01       Impact factor: 56.272

8.  Chop-lump tests for vaccine trials.

Authors:  Dean Follmann; Michael P Fay; Michael Proschan
Journal:  Biometrics       Date:  2009-02-05       Impact factor: 2.571

  8 in total
  1 in total

1.  Ridge Penalization in High-Dimensional Testing With Applications to Imaging Genetics.

Authors:  Iris Ivy Gauran; Gui Xue; Chuansheng Chen; Hernando Ombao; Zhaoxia Yu
Journal:  Front Neurosci       Date:  2022-03-24       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.